Answers are grounded in this paper and cite their sources.
Research reveals that anxiety and worry affect cognitive performance in midlife women, suggesting treatment benefits for APOE4 carriers.
Findings underscore the importance of anxiety and worry for women's cognitive performance at midlife among APOE4 carriers. They suggest the potential value of treating anxiety symptoms in APOE4 carriers to support women's cognition at midlife and beyond.
No takes yet. Share an insight, caveat, or question.
Harrison et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: